<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03924258</url>
  </required_header>
  <id_info>
    <org_study_id>CARENFER IC</org_study_id>
    <nct_id>NCT03924258</nct_id>
  </id_info>
  <brief_title>Study of the Prevalence of Iron Deficiency in Patients With Heart Failure</brief_title>
  <acronym>CARENFER IC</acronym>
  <official_title>Study of the Prevalence of Iron Deficiency in Patients With Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VIFORFRANCE</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VIFORFRANCE</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Despite its known prevalence in Heart Failure, a recent study conducted by Prof. Cacoub
      (unpublished) on the French national health insurance database showed that iron deficiency
      was a poorly diagnosed and poorly treated comorbidity. In chronic diseases including Heart
      Failure, Transferrin Saturation Factor is only performed in about 10% of cases while it is
      recommended for patients with Heart Failure (French Health High Authority 2011). The purpose
      of this study is to obtain current data on the prevalence of iron deficiency in France in
      patients with Heart Failure, applying the recommendations of European Society of Cardiology
      and French Health High Authority (determination of ferritinemia and Transferrin Saturation
      Factor).
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 15, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Complete blood iron status</measure>
    <time_frame>One day</time_frame>
    <description>ferritin, Transferrin Saturation Factor</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1300</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>HEART FAILURE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with Heart Failure diagnosis</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Iron status testing</intervention_name>
    <description>Blood sample for iron status testing</description>
    <arm_group_label>HEART FAILURE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient, male or female, over 18 years of age

          -  Patient present at the hospital on the day of the study

          -  Diagnosis of Heart Failure (acute or chronic) regardless of left ventricular ejection
             fraction (LVEF)

          -  Patient with signed consent

        Exclusion Criteria:

          -  Protected patient: major under guardianship, tutorship or other legal protection,
             deprived of liberty by judicial or administrative decision

          -  Pregnant or breastfeeding woman
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 18, 2019</study_first_submitted>
  <study_first_submitted_qc>April 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2019</study_first_posted>
  <last_update_submitted>April 18, 2019</last_update_submitted>
  <last_update_submitted_qc>April 18, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

